BYOMass Company

BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.


Investors

Last Funding Type: Venture - Series Unknown
Headquarters: Sudbury, Massachusetts, United States
Founded Date: 2017
Investor Type: Company
Last Funding Date: 2019
Total Funding: 1500000
Technology: Geroscience
Employee Number: 1-10
Number Of Exists: Venture - Series Unknown
Investors Number: 1
Industry: Biotechnology